Clinical trials of Ebola vaccine must continue despite fall in number of cases

Clinical trials of a vaccine against Ebola virus disease being conducted in west Africa must continue even if there are not enough definitive data on the vaccine’s effectiveness, a report by a panel of international experts has said.1

The panel, convened by the Wellcome Trust and the University of Minnesota’s Center for Infectious Disease Research and Policy, urged the continuation of the trials despite a recent fall in the disease’s incidence. It said that safety and immunogenicity data derived from the trials will be essential for determining whether to use the vaccines …